Robuta

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-10275&loc=0&rl=2&tid=PrE1702 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC... Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients non interventional studyprospectivecomparing https://www.mdpi.com/2072-6694/15/18/4436 COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected... Combined BRAF/MEK-inhibition constitutes a relevant treatment option for BRAF-mutated advanced melanoma. The prospective, non-interventional COMBI-r study... non interventional study